<DOC>
	<DOCNO>NCT01024062</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety paclitaxel give weekly patient advanced recurrent non-small cell lung cancer</brief_summary>
	<brief_title>Phase II Study Weekly Paclitaxel ( BMS-181339 ) Patient With Non-Small Cell Lung Cancer ( NSCLC )</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Patients prior chemotherapy meet either list : Patient stage IIIB IV disease Patients recurrent disease follow potentially curative surgical resection Patients previous chemotherapy one regimen Patients serious , uncontrolled medical illness Patients previous therapy taxanes</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>